Herpesvirus infection/injury govern fibrocyte recruitment and activation
疱疹病毒感染/损伤控制纤维细胞的募集和激活
基本信息
- 批准号:7363882
- 负责人:
- 金额:$ 37.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2012-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAlveolarAlveolar MacrophagesAnimal ModelB-LymphocytesBlood CirculationBone MarrowCellsCorrelative StudyCytolysisDataDepositionDevelopmentDinoprostoneDiseaseEicosanoidsEpithelial CellsEpstein-Barr Virus InfectionsEventExtracellular MatrixFibroblastsFibrosisFluoresceinFluoresceinsGenerationsHamman-Rich syndromeHerpesviridae InfectionsHumanHuman Herpesvirus 4Immune responseInfectionInflammationInjuryInterferonsInterleukin-13IsothiocyanatesKineticsLeadLeukocytesLeukotrienesLungLyticLytic PhaseMediator of activation proteinMesenchymalMusPathogenesisPatientsPlayProcessProductionPropertyPulmonary FibrosisRecruitment ActivityResearchRoleSiteTherapeuticViralVirus DiseasesWorkWound Healingabstractingbeta-Chemokinescell injurycysteinyl-leukotrienecytokineinsightinterstitiallatent infectionlung injurymacrophagemembermigrationnovelrepairedresearch studyresponse
项目摘要
Project Summary/Abstract
Pulmonary fibrosis may result from dysregulated wound healing responses to sequential lung injuries.
Recruitment of circulating bone-marrow-derived mesenchymal precursors (fibrocytes) is crucial for a
fibroproliferative host response post-injury. Fibrocytes contribute to extracellular matrix (ECM) generation and
promote fibrosis through the secretion of profibrotic/proinflammatory factors. A focal alveolar epithelial cell
(AEC) injury is believed to be the initiating event of the fibrotic process. The etiologic agents of lung injury are
unknown but latent viral infections, especially by members of the herpesvirinae have been associated with
idiopathic pulmonary fibrosis (IPF). Viral infection might influence fibroproliferative responses via lysis of
parenchymal lung cells or by inducing alterations in the function(s) of resident or recruited cells. Infection of
mice with MHV-68 (a murine gammaherpesvirus) results in both lytic and latent infection of AECs and mimics
human infection with Epstein-Barr virus (EBV). Our preliminary data demonstrate 1) MHV-68 infection
augments fluorescein isothiocyanate (FITC)-induced lung fibrosis when given both prior to or after the fibrotic
insult. 2) Fibrocytes are recruited to the lung in response to MHV-68 infection. 3) MHV-68 infection results in
the generation of cysteinyl leukotrienes (cys LTs) which can induce migration and activation of fibrocytes.
4) MHV-68 can infect fibrocytes and enhance their proliferation. 5) The additional alveolar injury induced by
FITC, induces a dysregulated cytokine and eicosanoid response which favors fibrocyte proliferation,
differentiation and ECM deposition. We hypothesize that increased fibrosis following MHV-68
infection/FITC injury is the result of enhanced recruitment, proliferation and differentiation of
fibrocytes. Recruitment and proliferation are increased due to releases of cys LTs and CC chemokines
by resident cells of the lung. Differentiation is enhanced by production of altered ratios of fibrocyte
stimulatory and protective molecules by parenchymal and recruited cells. Completion of the following
specific aims will provide new information regarding mechanisms that lead to generation of or exacerbation of
pulmonary fibrosis. Aim 1) To determine the kinetics and role of alveolar MHV-68 infection in augmentation of
FITC-induced pulmonary fibrosis; Aim 2) To determine whether MHV-68 infection alters the secretion of pro-
or anti-fibrotic mediators by AECs, alveolar macrophages (AMs), interstitial macrophages (IMs) and B cells and
to perform correlative studies in human AMs infected with EBV; Aim 3) To determine whether MHV-68
infection recruits more fibrocytes to the lung, whether MHV-68 or EBV infection alters fibrocytes and fibroblasts
and to determine the role of cys LTs in MHV-68-induced recruitment of fibrocytes and augmentation of fibrosis. Project Narrative/Relevance
The experiments proposed in this application will provide mechanistic insight into the role that viral infections
may play in predisposing people to the development of fibrosis. Research will also address the role that viral
infections play in exacerbating disease in patients with established fibrosis. Finally, this work will explore the
therapeutic potential of anti-leukotriene strategies to limit viral-induced exacerbations of fibrosis.
项目总结/摘要
肺纤维化可能是由于对连续性肺损伤的创伤愈合反应失调所致。
循环骨髓来源的间充质前体细胞(纤维细胞)的募集对于一个人的健康至关重要。
损伤后纤维增生宿主反应。纤维细胞有助于细胞外基质(ECM)的产生,
通过分泌促纤维化/促炎因子促进纤维化。局灶性肺泡上皮细胞
(AEC)损伤被认为是纤维化过程的起始事件。肺损伤的病因是
未知但潜伏的病毒感染,特别是疱疹病毒亚科成员的感染,
特发性肺纤维化(IPF)。病毒感染可能通过溶解
实质肺细胞或通过诱导驻留或募集的细胞的功能改变。感染
感染MHV-68(一种鼠γ疱疹病毒)的小鼠导致AEC和模拟物的溶解性和潜伏性感染
人类感染EB病毒(EBV)。我们的初步数据表明:1)MHV-68感染
增强异硫氰酸荧光素(FITC)诱导的肺纤维化时,给予之前或之后的纤维化
侮辱。2)纤维细胞响应于MHV-68感染被募集到肺。3)MHV-68感染导致
半胱氨酰白三烯(cys LTs)的产生可诱导纤维细胞的迁移和活化。
4)MHV-68可感染纤维细胞并促进其增殖。5)致额外肺泡损伤
FITC诱导有利于纤维细胞增殖的失调的细胞因子和类花生酸应答,
分化和ECM沉积。我们假设MHV-68后纤维化增加
感染/FITC损伤是增强的募集、增殖和分化的结果,
纤维细胞由于cys LT和CC趋化因子的释放,募集和增殖增加
由肺部的常驻细胞引起。通过改变纤维细胞的比例,
实质和募集细胞的刺激和保护分子。完成以下
具体目标将提供有关导致产生或加剧的机制的新信息
肺纤维化。目的1)确定肺泡MHV-68感染的动力学和作用,
FITC诱导的肺纤维化;目的2)确定MHV-68感染是否改变了前
或AEC、肺泡巨噬细胞(AM)、间质巨噬细胞(IM)和B细胞的抗纤维化介质,
目的3)确定MHV-68是否与EB病毒感染有关,
无论是MHV-68还是EBV感染改变了纤维细胞和成纤维细胞,
并确定cys LT在MHV-68诱导的纤维细胞募集和纤维化增强中的作用。项目叙述/相关性
在本申请中提出的实验将提供对病毒感染的作用的机制性见解,
可能会使人们容易患上纤维化。研究还将探讨病毒在
感染在已确定的纤维化患者中加重疾病中起作用。最后,这项工作将探讨
抗白三烯策略限制病毒诱导的纤维化恶化的治疗潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Galen B Toews其他文献
Galen B Toews的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Galen B Toews', 18)}}的其他基金
Herpesvirus infection/injury govern fibrocyte recruitment and activation
疱疹病毒感染/损伤控制纤维细胞的募集和激活
- 批准号:
7575786 - 财政年份:2008
- 资助金额:
$ 37.64万 - 项目类别:
Herpesvirus infection/injury govern fibrocyte recruitment and activation
疱疹病毒感染/损伤控制纤维细胞的募集和激活
- 批准号:
7771646 - 财政年份:2008
- 资助金额:
$ 37.64万 - 项目类别:
Regulation of fibrosis by alveolar cells expressing CCR2
表达 CCR2 的肺泡细胞对纤维化的调节
- 批准号:
6565048 - 财政年份:2001
- 资助金额:
$ 37.64万 - 项目类别:
SCOR in Pathobiology of Fibrotic Lung Disease
SCOR 在纤维化肺疾病病理学中的应用
- 批准号:
6819988 - 财政年份:2001
- 资助金额:
$ 37.64万 - 项目类别:
SCOR in Pathobiology of Fibrotic Lung Disease
SCOR 在纤维化肺疾病病理学中的应用
- 批准号:
6998978 - 财政年份:2001
- 资助金额:
$ 37.64万 - 项目类别:
SCOR in Pathobiology of Fibrotic Lung Disease
SCOR 在纤维化肺疾病病理学中的应用
- 批准号:
6695623 - 财政年份:2001
- 资助金额:
$ 37.64万 - 项目类别:
SCOR in Pathobiology of Fibrotic Lung Disease
SCOR 在纤维化肺疾病病理学中的应用
- 批准号:
6346721 - 财政年份:2001
- 资助金额:
$ 37.64万 - 项目类别:
SCOR in Pathobiology of Fibrotic Lung Disease
SCOR 在纤维化肺疾病病理学中的应用
- 批准号:
6620068 - 财政年份:2001
- 资助金额:
$ 37.64万 - 项目类别:
EPITHELIAL CELL/MACROPHAGE INTERACTIONS IN LUNG FIBROSIS
肺纤维化中的上皮细胞/巨噬细胞相互作用
- 批准号:
6410569 - 财政年份:2000
- 资助金额:
$ 37.64万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.64万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.64万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.64万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.64万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.64万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.64万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.64万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.64万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.64万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.64万 - 项目类别:
Research Grant